Jazz Pharmaceuticals plc
JAZZBiotechnology
$215.98+3.92%As of Oct 30vs prior close
- Market cap
- $14B
- P/E (TTM)
- 14.2×
- P/E (FY1)
- 13.8×
- Implied growth
- -1.2%
- From 52W high
- −17.45%
- EPS (LTM)
- $14.63
- Revenue (LTM)
- $4.6B
- Net margin
- 20.45%
Nomior Score
80
Discounted QualityTop 2% of the scored universe
Growth51
Quality81
Value68
Momentum91
Resilience52
Growth
+12.42%revenue a year over 9 fiscal years
YE16 $1.5BLTM $4.6B
Connections
Revenue to profitQ2 YE26
16% of revenue became net profit, up 85 pts on a year.
Who owns it
2funds